Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,561.28
-8.4900-0.54%
Number of Gainers:- -
Number of Losers:7
Number of Flat:- -
PE:- -
High:1,579.75
Open:1,579.75
Low:1,559.99
Close:1,569.77
Volume:44.52M
Turnover:4.69B
Market Cap:1.63T
Float Cap:1.56T

Loading ...

Eli Lilly (LLY) Eyes Merida Deal As Trial Data Strengthens Autoimmune Push

Simply Wall St.
·
Sep 01

Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?

Simply Wall St.
·
Sep 01

New National Essential Medicines List Takes Effect September 1, Introducing Semaglutide Injection (Novotai) as a New Option for Primary Diabetes Management

Stock News
·
Sep 01

Dow Jones Top Company Headlines at 9 PM ET: Anthropic Signs $35 Billion Cloud Deal Backed by Nvidia | UPS ...

Dow Jones
·
Sep 01

Did Targeted XFG COVID Shots Just Recenter Pfizer's (PFE) Post‑Pandemic Investment Narrative?

Simply Wall St.
·
Sep 01

1 Weight Loss Drugs Effective Even at Low Starter Doses

Reuters
·
Sep 01

Dow Jones Top Company Headlines at 5 PM ET: FTC Files Lawsuit Alleging Amazon Deceived Advertisers | State ...

Dow Jones
·
Sep 01

Ataibeckley - Hart-Scott-Rodino Waiting Period for Merger with Eli Lilly Expired on Aug 28, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 01

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 01

Sector Update: Healthcare Stocks Decline Monday Afternoon

MT Newswires Live
·
Sep 01

Moderately bullish activity in Eli Lilly with shares down 1.26%

TIPRANKS
·
Sep 01

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Sep 01

Top Midday Stories: Stocks Fall, Oil Rises Amid Renewed Fighting in Middle East; Utility Shares Fall After California Wildfire Legislation

MT Newswires Live
·
Aug 31

Dow Jones Top Company Headlines at 11 am ET: GameStop Sees Higher Profit as eBay Investment Offsets Lower Sales | SLB ...

Dow Jones
·
Aug 31

Novo Nordisk Advances DKK 15 Billion Share Buyback Programme Through Late August 2026

TIPRANKS
·
Aug 31

Political and General News Events from August 31

Reuters
·
Aug 31

Lilly is Bigger than Ever. Why Its Latest $2.9 Billion Immunology Deal Makes Sense.

Dow Jones
·
Aug 31

Eli Lilly's Psoriasis Drug Trial Shows Sustained Positive Results

Dow Jones
·
Aug 31

Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What it Means for the Stock.

Dow Jones
·
Aug 31

Eli Lilly announces 52-week results from TOGETHER-PsO, TOGETHER-PsA

TIPRANKS
·
Aug 31